| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Medical Physiology, Panum Institute, University of Copenhagen, DK-2200 Copenhagen; 3 Department of Aviation Medicine, Rigshospitalet 7805, DK-2200 Copenhagen; 2 Department of Clinical Physiology, Herlev Hospital, DK-2730 Herlev; and 4 Department of Physiology and Pharmacology, University of Southern Denmark, DK-5000 Odense, Denmark
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The hypothesis that increases in plasma sodium induce natriuresis independently of changes in body fluid volume was tested in six slightly dehydrated seated subjects on controlled sodium intake (150 mmol/day). NaCl (3.85 mmol/kg) was infused intravenously over 90 min as isotonic (Iso) or as hypertonic saline (Hyper, 855 mmol/l). After Hyper, plasma sodium increased by 3% (142.0 ± 0.6 to 146.2 ± 0.5 mmol/l). During Iso a small decrease occurred (142.3 ± 0.6 to 140.3 ± 0.7 mmol/l). Iso increased estimates of plasma volume significantly more than Hyper. However, renal sodium excretion increased significantly more with Hyper (291 ± 25 vs. 199 ± 24 µmol/min). This excess was not mediated by arterial pressure, which actually decreased slightly. Creatinine clearance did not change measurably. Plasma renin activity, ANG II, and aldosterone decreased very similarly in Iso and Hyper. Plasma atrial natriuretic peptide remained unchanged, whereas plasma vasopressin increased with Hyper (1.4 ± 0.4 to 3.1 ± 0.5 pg/ml) and decreased (1.3 ± 0.4 to 0.6 ± 0.1 pg/ml) after Iso. In conclusion, the natriuretic response to Hyper was 50% larger than to Iso, indicating that renal sodium excretion may be determined partly by plasma sodium concentration. The mechanism is uncertain but appears independent of changes in blood pressure, glomerular filtration rate, the renin system, and atrial natriuretic peptide.
hypertonic sodium loading; osmoreceptors; renin-angiotensin-aldosterone system
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
IT HAS BEEN RECOGNIZED for decades that renal sodium excretion is modulated by changes in intravascular pressure and body fluid volume (e.g., Refs. 18, 25). In addition, results from a number of animal experiments indicate that stimulation of osmoreceptors located in the brain, the gut, and the liver may increase renal sodium excretion by mechanisms that are not dependent on changes in body fluid volume (7, 8, 12, 20-22, 34-36, 42, 43, 45, 46). In the same animal species, infusion of hypertonic saline has been found to induce a greater natriuresis than that produced by infusion of the same amount of sodium as an isotonic solution, although the former procedure induces the smallest increase in body fluid volume (14-16, 23, 28, 33). This excess natriuresis induced by hypertonic saline infusion may be mediated by stimulation of the above-mentioned sodium-regulating osmoreceptors and could be referred to as concentration-mediated or osmostimulated natriuresis.
Although sodium homeostasis may also be under osmoregulatory control in humans, concentration-mediated natriuresis has not been consistently verified in humans. In recent human studies from our laboratory, infusion of hypertonic saline was not associated with excess natriuresis (4-6). However, plasma sodium concentration was increased to rather modest levels, and it could be hypothesized that the absolute increase in plasma sodium concentration is of critical importance so that natriuresis is not mediated until sodium concentration reaches a certain level. The purpose of the present study was to compare the effects of hypertonic vs. isotonic saline loading in subjects that were water deprived for 14 h before the experiments to increase plasma sodium concentration to levels above those obtained in previous experiments.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Experiments were performed in six healthy male volunteers. Subjects were 22-29 yr old, weighing 62.6-83.9 kg. All gave informed consent, and the study was approved by the Ethics Committee of Copenhagen (JNR KF 01-104/95).
The subjects were investigated on three different study days, and before all experiments subjects accepted a controlled diet containing 150 mmol NaCl/day for 4 days. During this period, subjects were allowed to drink only tap water. Sodium turnover was assessed by measurements of 24-h urinary sodium excretion. The day before the experiment, subjects consumed their standard evening meal before 1800 and were not allowed any food or fluid intake after this time. The night before the experiment the subject slept at the laboratory. After consumption of a light standardized low-salt breakfast (2 slices of toast, 15 g marmalade, and 100 ml of tap water), two catheters (Venflon) were placed in superficial cubital veins for blood sampling and infusion of saline, respectively. Between 0800 and 0830, the subject emptied his bladder, and the experiment was initiated. The subject remained seated in an armchair throughout the experiment and was allowed to stand up only for micturition.
Each experiment lasted 6 h and was divided into four 90-min periods. After the baseline period, a sodium load of 3.85 mmol/kg body wt was infused over the following 90 min by an infusion pump. The load was infused as either 0.9% saline (isotonic) or as 5% saline (hypertonic) on separate days. Thus volumes of 25 and 4.5 ml/kg body wt were infused in the isotonic and hypertonic series, respectively. The time control series was without saline infusion but otherwise identical to the infusion series. The three experiments on each subject were separated by at least 8 days.
Urine was collected by voluntary micturition during the last minutes of each 90-min period. The excreted volume was immediately replaced by drinking the same amount of tap water plus 45 ml (0.5 ml/min) as replacement for insensible water loss.
Blood for measurements of hematocrit (Hct), plasma osmolality, oncotic
pressure, and plasma concentrations of sodium, protein, albumin, and
creatinine was sampled in heparinized tubes in the middle of each
period and during the last 10 min of saline infusion. At the same time,
blood for hormone analyses was collected in prechilled polyethylene
tubes containing aprotinin and EDTA. A total of 150 ml of blood was
collected throughout each experiment. Blood samples were replaced by
similar amounts of isotonic saline immediately after each sampling. The
samples were centrifuged at +4oC immediately after
sampling, and plasma for determination of hormone concentrations was
stored at 
18oC and analyzed within 6 mo.
Hct was determined by centrifugation (Microfuge, Christ). Oncotic pressure was determined by a colloid osmometer (4400 Colloid Osmometer, Wescor). Hemoglobin (Hb), Hct, and plasma concentrations of sodium, potassium, albumin, and protein were measured by a multianalyzer (SMAC3, Bayer). Urine sodium concentrations were measured by flame photometry and osmolality by freezing-point depression (model 3DII, Advanced Instruments). Concentrations of creatinine were measured by conventional spectrophotometry based on the Jaffé reaction.
Arterial systolic and diastolic pressures were recorded
semiautomatically by oscillometry four times during each experimental period (Propaq 102, Dameca), and the mean of these values was used to
calculate mean arterial pressure (MAP) from the following formula:
MAP = diastolic pressure + (1/3) × pulse pressure.
Percent change in plasma volume (PV) was calculated from the formula
(26)
|
![× (100 − Hct<SUB>2</SUB>/100 − Hct<SUB>1</SUB>) − 1] × 100](/content/vol282/issue6/fulltext/R1754/img002.gif)
|
Statistics. Results are presented as means ± SE. Data were subjected to one-way analysis of variance for repeated measures (44). In case of significantly large F values of the ANOVA, all possible differences were evaluated sequentially by Newman-Keuls test. Selected differences between two series, e.g., at the time of maximal deviation, were evaluated using paired Student's t-test. Level of significance was in all cases 0.05.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Plasma sodium concentration increased with hypertonic saline
infusion from 142.0 ± 0.6 to 146.2 ± 0.5 mmol/l and
decreased slightly but significantly during time control (141.7 ± 0.7 to 140.3 ± 0.6 mmol/l) and isotonic saline loading
(142.3 ± 0.6 to 140.3 ± 0.7 mmol/l). Changes in plasma
osmolality followed the same pattern (Fig.
1).
|
Plasma oncotic pressure was identical before saline infusion and
decreased in both saline series (Fig. 2).
The consistent tendency toward lower values in the isotonic series was
evaluated by averaging the observations made during and after the
infusion in each subject. After saline loading, the values found in the isotonic series were marginally but significantly smaller than those of
the hypertonic series (23.0 ± 0.5 vs. 23.8 ± 0.3 mmHg, P < 0.05). No changes were observed during time
control. Similar trends were observed for Hb and plasma concentration
of protein and albumin (data not shown). Calculated change in plasma
volume increased significantly more during isotonic than during
hypertonic saline infusion (15 ± 2 vs. 11 ± 1%, Fig. 2).
|
Sodium excretion remained stable during time control but increased in
both saline series (Fig. 3). The
natriuresis after hypertonic saline infusion exceeded that after
isotonic saline infusion in the first period after infusion (291 ± 25 vs. 199 ± 24 µmol/min) as well as in the final period of
observation (300 ± 23 vs. 224 ± 23 µmol/min).
|
Urine flow remained unchanged during time control but increased from
0.6 ± 0.1 to 1.4 ± 0.1 ml/min after hypertonic saline infusion and from 0.6 ± 0.1 to 2.6 ± 0.7 ml/min after
isotonic saline infusion (Fig. 4). Free
water clearance decreased from 1.2 ± 0.1 to 2.3 ± 0.1 ml/min after hypertonic saline infusion and remained statistically
unchanged in the other series (Fig. 4).
|
There were no changes in arterial blood pressure in the isotonic series
or during time control, but MAP decreased significantly by ~4 mmHg in
the hypertonic series as a result of small decreases in diastolic and
systolic arterial pressures (Table 1).
Heart rate decreased in all series. Creatinine clearance did not change measurably in any of the series (Table 1).
|
Plasma hormone concentrations are presented in Fig.
5 and Fig.
6. Isotonic and hypertonic saline
infusion induced similar decreases in plasma renin activity, ANG II
concentration, and aldosterone concentration. No changes were observed
during time control except for aldosterone concentration, which
increased during the second and third period of observation, returning
to baseline in the final period. Plasma AVP concentration increased from 1.4 ± 0.4 to 3.1 ± 0.5 pg/ml during hypertonic saline
infusion and decreased from 1.3 ± 0.4 to 0.6 ± 0.1 pg/ml
during isotonic saline infusion. No changes were observed during time
control. Plasma concentration of ANP remained unchanged in all series.
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The purpose of the present study was to test the hypothesis that an increase in plasma sodium can induce natriuresis by a mechanism independent of changes in body fluid volume. The data support this hypothesis because hypertonic saline infusion induced an increase in renal sodium excretion that exceeded the natriuresis induced by isotonic saline infusion.
The experiments were performed under well-defined and strictly controlled conditions with regard to sodium status and water balance. Accordingly, baseline sodium concentrations and osmolality were very similar in the different experimental series, at levels to be expected after overnight fasting. During salt loading, isotonic saline infusion caused no further increase in plasma tonicity, whereas hypertonic saline infusion increased plasma sodium concentration and plasma osmolality quite substantially, but still not to a degree that exceeds the physiological levels induced by, for example, moderate to severe dehydration (11, 40). While only the hypertonic saline load induced an osmotic stimulus, the isotonic load induced a more powerful volumetric stimulation as estimated from the calculated changes in plasma volume and oncotic pressure. This is in accord with previous observations (4, 6, 23). All in all, it seems reasonable to argue that compared with isotonic loading, hypertonic saline loading induced a sizable osmotic stimulus at the expense of a smaller volumetric stimulus.
According to the classical concept of sodium balance being maintained primarily by volumetric control, the largest natriuresis should have been observed in the isotonic saline series. However, hypertonic saline loading increased sodium excretion significantly more than isotonic loading despite the smaller increase in volume. We therefore suggest that a substantial part of the natriuresis induced by hypertonic saline loading must be attributed to the increased osmotic concentration rather than to the change in body fluid volume. Previous investigations from our laboratory also support the concept of such a concentration-mediated natriuresis in dogs (20-23) as well as in humans (4, 6, 10). However, in our recent human investigations using a design very similar to the present, hypertonic and isotonic saline induced natriuretic responses that were statistically indistinguishable. Because identical natriuretic responses were obtained at different volumetric stimuli, it was argued that part of the natriuresis seen with hypertonic loading was caused by osmostimulation (4, 6). The present results provide a more direct and convincing evidence for a significant role of osmoreceptors in human sodium homeostasis.
The main difference between the present and the previous protocols is the degree of hypernatremia obtained with hypertonic sodium loading. In previous protocols the subjects received an initial water load before the salt loading, and consequently basal as well as postinfusion plasma sodium concentrations were lower than those presented here. The results suggest that the extent to which plasma sodium is elevated is of critical importance for the natriuretic response to osmostimulation. Furthermore, the present application of moderate dehydration and placement of the subject in the seated position is associated with a central blood volume that is reduced compared with the usual conditions of slight overhydration, high sodium intake, and supine position (4, 6). Because osmomediated natriuresis was more evident under the present circumstances of relative hypovolemia, it seems that the degree of hypernatremia is more important as a stimulus to sodium excretion than any additional increase in central blood volume obtainable by changes in, for example, posture or dietary sodium intake.
Natriuretic mechanisms. The regulation of renal sodium excretion is multifactorial, and the natriuresis after volume loading is generally considered to be mediated by changes in physical as well as neural and endocrine factors. Data from several animal experiments indicate that the natriuretic response to osmostimulation is facilitated by stimulation of specific osmo- or sodium receptors located primarily in the brain (7, 8, 12, 20-22, 34-36, 42, 43, 45, 46) but possibly also in the gut or the liver (for reviews, see Refs. 13, 27, 39). The efferent signal in the natriuresis of central osmostimulation is most likely mediated by a humoral factor because renal denervation does not abolish the natriuresis of osmostimulation (22), but this factor has not been positively identified. In the present study, we measured several well-known mediators of sodium excretion to clarify the mechanism of the osmostimulated natriuresis.
Both loading procedures consistently suppressed the renin-angiotensin-aldosterone axis, suggesting that at least a part of the natriuretic response to isotonic as well as hypertonic sodium loading was mediated by changes in this system. Previous findings confirm the notion that ANG II is one of the main controllers of renal sodium excretion (1, 4-6, 41). However, none of the components in the renin-angiotensin-aldosterone system was reduced more during hypertonic than during isotonic saline infusion. On the contrary, isotonic loading tended to suppress these parameters more than hypertonic loading although this tendency did not reach statistical significance. From these results, it seems quite unlikely that the renin system was responsible for the concentration-mediated part of the natriuresis. Plasma ANP remained unchanged in all series, and it is very unlikely that the changes in sodium excretion were induced by ANP. This is in agreement with our previous findings in seated as well as supine subjects, where similar doses of sodium increased renal sodium excretion several times without any change in the plasma concentration of ANP (4-6). During isotonic saline infusion, AVP secretion was probably suppressed by increments in central blood volume, which have been found to be a very potent inhibitor of AVP secretion, at least in dogs (2). In addition, plasma sodium decreased by just a few millimoles per liter, adding to the suppression of AVP secretion. During hypertonic saline loading, the osmotic stimulus dominated over the volumetric stimuli as expected, and plasma AVP increased significantly. It is unlikely that baroreceptor unloading accounted for the increased AVP release because there was no change in pulse pressure, probably no unloading of cardiopulmonary receptors, and only a 4-mmHg decrease in MAP (24). The effect of AVP on sodium excretion is controversial. In several animal species such as dog, rat, and sheep, there are results to indicate that AVP can promote natriuresis (9, 32). However, this has to our knowledge never been confirmed in humans. In fact, infusion of AVP in doses that increase plasma concentration by only a few picograms per milliliter actually inhibits renal sodium excretion in healthy humans (3). It thus seems unlikely that the present increase in AVP observed during hypertonic saline infusion is responsible for the excess natriuresis observed in this series. However, control experiments during which isotonic expansion is accompanied by infusion of suitable amounts of vasopressin to induce identical increments in plasma AVP have not been performed. It has been suggested that the concentrating ability of the kidneys is a major limiting factor in the excretion of a saline load (17). However, this did not seem to be of critical importance during the present circumstances because sodium excretion in the hypertonic series indeed exceeded that of the isotonic series, despite significantly lower free water clearances. On the other hand, it may explain why the urine flow increased during hypertonic saline loading despite significant increases in plasma AVP concentration. Hemodilution has been found to be a potent natriuretic factor (19, 29-31), and this probably contributed to the natriuresis observed in both infusion series. However, because the hemodilution seemed most pronounced during isotonic saline loading, this cannot be the mechanism of excess natriuresis after hypertonic saline loading. Arterial blood pressure decreased slightly after hypertonic saline loading and remained unchanged in the other series. It is, therefore, not possible that sodium excretion increased because of pressure natriuresis. In addition, there were no measurable changes in creatinine clearance. Still it must be considered that the increase in plasma sodium concentration most likely increased the filtered load of sodium and that this could be responsible for at least part of the natriuretic response to hypertonic saline infusion. On the other hand, we have previously shown that an opposite but quantitatively similar decrease in filtered load of sodium induced by oral water loading has no antinatriuretic effects at all (5).Summary. The findings demonstrate for the first time in humans that the natriuresis after hypertonic saline is larger than that of isotonic saline. Our data indicate that this excess natriuresis is induced by the increase in sodium concentration and not by changes in body fluid volume or pressure. The combination of overnight water deprivation, normal sodium intake, and the placement of the subject in the seated position provided an experimental situation characterized by higher plasma osmolality and lower central blood volume compared with the conditions of our previous designs, in which hypertonic saline infusion failed to induce excess natriuresis (4-6). Thus the level to which plasma sodium concentration is increased seems to be of critical importance to the mechanism of osmomediated sodium excretion. The effector mechanism behind the excess sodium excretion cannot be positively identified from the present data, but it is probably not mediated by changes in arterial blood pressure, by oncotic pressure, by suppression of the renin-angiotensin-aldosterone system, or by increases in ANP or vasopressin. Finally, the results confirm the previous finding (6, 37) that the seated position is a very stable experimental position with regard to hemodynamic, humoral, and renal excretory functions.
Perspectives
The maintenance of a proper sodium balance is mediated by a complex interplay of multiple neuroendocrine and physical factors. Changes in body fluid volume may still be considered a very important stimulus to renal sodium excretion, but the present data provide strong evidence that changes in concentration of the body fluids are equally important in the maintenance of a normal sodium balance.Disturbances in sodium handling are part of the pathophysiological changes in clinically important conditions such as congestive heart failure, edema formation, and some forms of arterial hypertension. A precise understanding of the mechanisms involved in normal regulation of renal sodium excretion may help clarify the pathophysiology behind these clinical conditions. It is suggested that, in future clinical investigations of, for example, salt-sensitive hypertension, a possible dysfunction of osmomediated sodium excretion should also be taken into consideration.
| |
ACKNOWLEDGEMENTS |
|---|
We thank B. Svensson, B. Lynderup Christensen, S. Kramer Hansen, I. Pedersen, B. Sørensen, and T. Eidsvold for expert technical assistance. We also thank Dr. S. Levin Nielsen for technical support and for providing us with the experimental facilities.
| |
FOOTNOTES |
|---|
The experiments were supported by The Danish Medical Research Council, Danish Foundation for the Advancement of Medical Science, Kong Christian den Tiendes Foundation, Engineer August Frederik Wedell Erichsens Foundation, Direktør Jacob Madsens & Hustru Olga Madsens Foundation, and The Danish Heart Foundation.
Preliminary results were presented at Experimental Biology 99, Washington DC, April 1999 and the 2nd Federation of European Physiological Societies Congress, Prague, Czech Republic, June 1999.
Address for reprint requests and other correspondence: P. Bie, Dept. of Physiology and Pharmacology, Univ. of Southern Denmark, 21 Winsløwparken, DK-5000 Odense, Denmark (E-mail: pbie{at}health.sdu.dk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published February 14, 2002;10.1152/ajpregu.00732.2001
Received 7 December 2001; accepted in final form 2 February 2002.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Andersen, JL,
Andersen LJ,
Sandgaard NCF,
and
Bie P.
Volume expansion natriuresis during servo control of systemic blood pressure in conscious dogs.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R19-R27,
2000
2.
Andersen, JL,
Andersen LJ,
Thrasher TN,
Keil LC,
and
Ramsay DJ.
Left heart and arterial baroreceptors interact in control of plasma vasopressin, renin, and cortisol in awake dogs.
Am J Physiol Regulatory Integrative Comp Physiol
266:
R879-R888,
1994
3.
Andersen, LJ,
Andersen JL,
Schütten HJ,
Warberg J,
and
Bie P.
Antidiuretic effect of subnormal levels of arginine vasopressin in normal humans.
Am J Physiol Regulatory Integrative Comp Physiol
259:
R53-R60,
1990
4.
Andersen, LJ,
Jensen TUS,
Bestle MH,
and
Bie P.
Isotonic and hypertonic sodium loading in supine humans.
Acta Physiol Scand
166:
23-30,
1999[Web of Science][Medline].
5.
Andersen, LJ,
Jensen TUS,
Bestle MH,
and
Bie P.
Gastrointestinal osmoreceptors and renal sodium excretion in humans.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R287-R294,
2000
6.
Andersen, LJ,
Norsk P,
Johansen LB,
Christensen P,
Engstrøm T,
and
Bie P.
Osmoregulatory control of renal sodium excretion after sodium loading in humans.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1833-R1842,
1998
7.
Andersson, B,
Dallman MF,
and
Olsson K.
Evidence for a hypothalamic control of renal sodium excretion.
Acta Physiol Scand
75:
496-510,
1969[Web of Science][Medline].
8.
Andersson, B,
Jobin M,
and
Olsson K.
Stimulation of urinary salt excretion following injections of hypertonic NaCl-solution into the 3rd brain ventricle.
Acta Physiol Scand
67:
127-128,
1966[Web of Science][Medline].
9.
Balment, RJ,
Brimble MJ,
Forsling ML,
and
Musabayane CT.
Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range.
J Physiol
352:
517-526,
1984
10.
Bestle, MH,
Norsk P,
and
Bie P.
Fluid volume and osmoregulation in humans after a week of head down bed rest.
Am J Physiol Regulatory Integrative Comp Physiol
281:
R310-R317,
2001
11.
Black, DAK,
McCrane RA,
and
Young WF.
A study of dehydration by means of balance experiments.
J Physiol
102:
406-414,
1944.
12.
Blaine, EH,
Denton DA,
McKinley MJ,
and
Weller S.
A central osmosensitive receptor for renal sodium excretion.
J Physiol
244:
497-509,
1975
13.
Bourque, CW,
Oliet SHR,
and
Richard D.
Osmoreceptors, osmoreception, and osmoregulation.
Front Neuroendocrinol
15:
231-274,
1994[Web of Science][Medline].
14.
Childers, JW,
and
Schneider EG.
Effect of hypertonic and hypotonic infusions on aldosterone in conscious sodium-depleted dogs.
Clin Sci
61:
191-199,
1981[Medline].
15.
Childers, JW,
and
Schneider EG.
Aldosterone and the enhanced natriuresis of hypertonic infusions in the dog.
Am J Physiol Renal Fluid Electrolyte Physiol
242:
F30-F37,
1982
16.
Chodobski, A,
and
McKinley MJ.
Cerebral regulation of renal sodium excretion in sheep infused intravenously with hypertonic NaCl.
J Physiol
418:
273-291,
1989
17.
Choukroun, G,
Schmitt F,
Martinez F,
Drueke TB,
and
Bankir L.
Low urine flow reduces the capacity to excrete a sodium load in humans.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1726-R1733,
1997[Web of Science].
18.
Cowley, AW, Jr.
Long-term control of arterial blood pressure.
Physiol Rev
72:
231-300,
1992
19.
Cowley, AW, Jr.,
and
Skelton MM.
Dominance of colloid osmotic pressure in renal excretion after isotonic volume expansion.
Am J Physiol Heart Circ Physiol
261:
H1214-H1225,
1991
20.
Emmeluth, C,
Drummer C,
Gerzer R,
and
Bie P.
Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade.
Acta Physiol Scand
151:
403-411,
1994[Web of Science][Medline].
21.
Emmeluth, C,
Drummer C,
Gerzer R,
and
Bie P.
Roles of cephalic Na+ concentration and urodilatin in control of renal Na+ excretion.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F513-F516,
1992
22.
Emmeluth, C,
Goetz KL,
Drummer C,
Gerzer R,
Forssmann WG,
and
Bie P.
Natriuresis caused by increased carotid Na+ concentration after renal denervation.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F510-F517,
1996
23.
Emmeluth, C,
Schütten HJ,
Knigge U,
Warberg J,
and
Bie P.
Increase in plasma sodium enhances natriuresis in response to a sodium load unable to change plasma atrial peptide concentration.
Acta Physiol Scand
140:
119-127,
1990[Web of Science][Medline].
24.
Goldsmith, SR.
The effect of moderate hypotension on vasopressin levels in normal humans.
Am J Med Sci
298:
295-298,
1989[Web of Science][Medline].
25.
Guyton, AC.
Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models.
Am J Physiol Regulatory Integrative Comp Physiol
259:
R865-R877,
1990
26.
Harrison, MH.
Effects of thermal stress and exercise on blood volume in humans.
Physiol Rev
65:
149-209,
1985
27.
Hosomi, H,
and
Morita H.
Hepatorenal and hepatointestinal reflexes in sodium homeostasis.
News Physiol Sci
11:
103-107,
1996
28.
Huang, W,
Lee SL,
and
Sjöquist M.
Natriuretic role of endogenous oxytocin in male rats infused with hypertonic NaCl.
Am J Physiol Regulatory Integrative Comp Physiol
268:
R634-R640,
1995
29.
Johansen, LB,
Bie P,
Warberg J,
Christensen NJ,
Hammerum M,
Videbaek R,
and
Norsk P.
Hemodilution, central blood volume, and renal responses after an isotonic saline infusion in humans.
Am J Physiol Regulatory Integrative Comp Physiol
272:
R549-R556,
1997
30.
Johansen, LB,
Bie P,
Warberg J,
Christensen NJ,
and
Norsk P.
Role of hemodilution on renal responses to water immersion in humans.
Am J Physiol Regulatory Integrative Comp Physiol
269:
R1068-R1076,
1995
31.
Johansen, LB,
Pump B,
Warberg J,
Christensen NJ,
and
Norsk P.
Preventing hemodilution abolishes natriuresis of water immersion in humans.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R879-R888,
1998
32.
Lichardus, B.,
Foldes O.,
Styk J.,
Zemankova A.,
and
Kovacs L.
On the role of digoxin-like substances, ANP, and AVP in natriuresis induced by hypertonic saline infusion in dogs.
J Cardiovasc Pharmacol
22, Suppl 2:
S82-S83,
1993.
33.
McKinley, MJ,
Lichardus B,
McDougall JG,
and
Weisinger RS.
Periventricular lesions block natriuresis to hypertonic but not isotonic NaCl loads.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F98-F107,
1992
34.
Mouw, DR,
and
Vander AJ.
Evidence for brain Na receptors controlling renal Na excretion and plasma renin activity.
Am J Physiol
219:
822-832,
1970.
35.
Mouw, DR,
Vander AJ,
Bourgoignie JJ,
Kutschinski SS,
and
Mathias NP.
Nonpressor mechanisms in CNS-induced natriuresis.
Am J Physiol Renal Fluid Electrolyte Physiol
237:
F157-F166,
1979
36.
Mouw, DR,
Vander AJ,
Landis C,
Kutschinski S,
Mathias N,
and
Zimmerman D.
Dose-response relation of CSF sodium and renal sodium excretion, and its absence in homozygous Brattleboro rats.
Neuroendocrinology
30:
206-212,
1980[Web of Science][Medline].
37.
Norsk, P,
Stadeager C,
Johansen LB,
Warberg J,
Bie P,
Foldager N,
and
Christensen NJ.
Volume-homeostatic mechanisms in humans during a 12-h posture change.
J Appl Physiol
75:
349-356,
1993
38.
Poulsen, K.,
and
Jørgensen J.
An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.
J Clin Endocrinol Metab
39:
816-825,
1974
39.
Sawchenko, PE,
and
Friedman MI.
Sensory functions of the liver
a review.
Am J Physiol Regulatory Integrative Comp Physiol
236:
R5-R20,
1979
40.
Shore, AC,
Markandu ND,
Sagnella GA,
Singer DR,
Forsling ML,
Buckley MG,
Sugden AL,
and
MacGregor GA.
Endocrine and renal response to water loading and water restriction in normal man.
Clin Sci
75:
171-177,
1988[Medline].
41.
Singer, DRJ,
Markandu ND,
Morton JJ,
Miller MA,
Sagnella GA,
and
MacGregor GA.
Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans.
Am J Physiol Renal Fluid Electrolyte Physiol
266:
F89-F93,
1994
42.
Thornborough, JR,
Passo SS,
and
Rothballer AB.
Forebrain lesion blockade of the natriuretic response to elevated carotid blood sodium.
Brain Res
58:
355-363,
1973[Web of Science][Medline].
43.
Thornborough, JR,
Passo SS,
and
Rothballer AB.
Receptors in cerebral circulation affecting sodium excretion in the cat.
Am J Physiol
225:
138-141,
1973.
44.
Winer, BJ.
Statistical Methods in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971.
45.
Zucker, IH,
and
Kaley G.
Natriuresis induced by intracarotid infusion of hypertonic NaCl.
Am J Physiol
230:
427-433,
1976.
46.
Zucker, IH,
Levine N,
and
Kaley G.
Third ventricular injection of hypertonic NaCl: effect of renal denervation on natriuresis.
Am J Physiol
227:
35-41,
1974.
This article has been cited by other articles:
|
|
 |
|
  E. J. Hoorn, M. C. Zillikens, H. A. P. Pols, A. H. J. Danser, F. Boomsma, and R. Zietse Osmomediated natriuresis in humans: the role of vasopressin and tubular calcium sensing Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3326 - 3333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bie, S. Molstrom, and S. Wamberg Normotensive sodium loading in conscious dogs: regulation of renin secretion during {beta}-receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R428 - R435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Molstrom, N. H. Larsen, J. A. Simonsen, R. Washington, and P. Bie Normotensive sodium loading in normal man: regulation of renin secretion during {beta}-receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R436 - R445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Hoorn and R. Zietse Reply Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4081 - 4081. [Full Text] [PDF]
|
|
|
|
|
|
M. Kjolby and P. Bie Chronic activation of plasma renin is log-linearly related to dietary sodium and eliminates natriuresis in response to a pulse change in total body sodium Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R17 - R25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Modi Avoiding hypernatraemic dehydration in healthy term infants Arch. Dis. Child., June 1, 2007; 92(6): 474 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Bourque, S. Ciura, E. Trudel, T. J. E. Stachniak, and R. Sharif-Naeini Hydromineral Neuroendocrinology: Neurophysiological characterization of mammalian osmosensitive neurones Exp Physiol, May 1, 2007; 92(3): 499 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Farquhar, E. E. Paul, A. V. Prettyman, and M. E. Stillabower Blood pressure and hemodynamic responses to an acute sodium load in humans J Appl Physiol, October 1, 2005; 99(4): 1545 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Lohmeier Neurohypophysial hormones Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R715 - R717. [Full Text] [PDF]
|
|
|
|
|
|
O. Skott Body sodium and volume homeostasis Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R14 - R18. [Full Text] [PDF]
|
|
|
|
|
|
P. B. Persson The kidney and hypertension Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1176 - R1178. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
, Time control; 
,
isotonic saline infusion; 
, hypertonic saline infusion.
* Significantly different from preinfusion value.
